A pharmacy-driven COPD TOC service did not significantly reduce the 30-day re-presentation rate, according to this study. It did discover that a sizable proportion of patients with COPD exacerbation who were admitted might require an inhaler change, and it illustrates the value of this kind of TOC service for seeing and fixing medication-related issues particular to this disease state. The percentage of patients receiving the entire intended intervention had room for improvement.